Jedidiah Monson, MD
Radiation Oncology · Fresno, CANPI 1669455390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,179 and has fallen 67.2% since, to $386 in 2025.
Across 213 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$1K
- Amgen$613
- AstraZeneca$397
- Ipsen Biopharmaceuticals, Inc$292
- Daiichi Sankyo Inc.$253
- Novartis$155
- plus $2K from 32 others
Across 1 payment — averaging $3071.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- EMD Serono, Inc.$3K
What the payments were for
- Food & beverage$4,476100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 96 | $1,043 |
| Amgen | 10 | $613 |
| AstraZeneca(2 entities) | 16 | $397 |
| Ipsen Biopharmaceuticals, Inc | 5 | $292 |
| Daiichi Sankyo Inc. | 9 | $253 |
| Novartis | 9 | $155 |
| Cardinal Health 108 LLC | 2 | $153 |
| Sirtex Medical Inc | 1 | $150 |
| Pharmacyclics LLC, An Abbvie Company | 6 | $142 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Johnson & Johnson | 7 | $118 |
| Coherus Oncology, Inc. | 1 | $113 |
| Varian Medical Systems, Inc. | 4 | $109 |
| Tersera Therapeutics LLC | 4 | $84 |
| AbbVie | 3 | $77 |
| Telix Pharmaceuticals | 3 | $63 |
| Pharmaessentia USA Corporation | 2 | $61 |
| Merck | 3 | $50 |
| Sobi, Inc | 2 | $47 |
| Beigene USA, Inc. | 3 | $44 |
| Dova Pharmaceuticals | 2 | $38 |
| Novocure Inc. | 2 | $34 |
| Pharmacosmos Therapeutics Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Tempus AI, Inc | 1 | $28 |
| Exelixis Inc. | 1 | $26 |
| GSK | 1 | $25 |
| Incyte Corporation | 1 | $25 |
| Immunocore Limited | 1 | $24 |
| Napo Pharmaceuticals Inc | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $16 |
| Seagen Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Epizyme, Inc. | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Bristol Myers Squibb | 1 | $12 |
| Karyopharm Therapeutics Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neulasta$292
- SOMATULINE DEPOT$223
- ONIVYDE$223
- SIR-Spheres Microspheres$150
- KANJINTI$146
- MVASI$146
- LUMAKRAS$123
- Udenyca$113
How this compares
$4,476 in reported general payments places this provider in the 80th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 11 | $369 |
| Tamsulosin Hcl | 11 | $207 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Fresno
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Arya AminiDuarte$265K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
- Felix FengSan Francisco$99K
- Hyun KimDuarte$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.